Involved margin of tongue cancer: The impact of tumor satellites on prognosis

Head and Neck

Volumn 30, Issue 7, 2008, Pages 845-851

  Yang, Tsung Lin ^a,b   Ko, Jenq Yuh ^a   Chang, Yih Leong ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Involved margin; Prognosis; Tongue cancer; Tumor satellites

Indexed keywords

TUMOR MARKER;

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHI SQUARE TEST; CLINICAL ARTICLE; FEMALE; FISHER EXACT TEST; GLOSSECTOMY; HUMAN; KAPLAN MEIER METHOD; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE; TONGUE CANCER; TREATMENT OUTCOME; TUMOR CELL; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; GLOSSECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TONGUE NEOPLASMS;

EID: 47549093214     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20789     Document Type: Article

References (28)

1. Looser K, Shah J, Strong E. The significance of 'positive' margins in surgically resected epidermoid carcinomas. Head Neck Surg 1978;1:107-111.
2. Vokes E, Weichselhaum R, Lippman S, Hong W. Head and neck cancer. N Engl J Med 1993;328:184-194.
3. Loree T, Strong E. Significance of positive margins in oral cavity squamous carcinoma. Am J Surg 1990;160:410-414.
4. van Es RJ, van Nieuw Amerongen N, Slootweg PJ, Egyedi P. Resection margin as a predictor of recurrence at the primary site for Tl and T2 oral cancers. Evaluation of histopathologic variables. Arch Otolaryngol Head Neck Surg 1996;122:521-525.
5. Bryne M, Koppang H, Lilleng R, Stene T, Bang G, Dabelsteen E. New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med 1989;18:432-437.
6. Brandwein-Gensler M, Teixeira M, Lewis C, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 2005;29:167-178.
7. Spiro RH, Guillamondegui O Jr, Paulino AF, Huvos AG. Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck 1999;21:408-413.
8. Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res 1987;95:229-249.
9. Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 2005;103:299-306.
10. Bryne M, Koppang H, Lilleng R, Kjaerheim A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 1992;166:375-381.
11. Bryne M, Boysen M, Alfsen C, et al. The invasive front of carcinomas. The most important area for tumour prognosis? Anticancer Res 1998;18:4757-464.
12. Howell G, Grandis J. Molecular mediators of metastasis in head and neck squamous cell carcinoma. Head Neck 2005;27:710-717.
13. Pyo S, Hashimoto M, Kim Y, et al. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. J Craniomaxillofac Surg 2007;35:1-9.
14. Mendenhall W, Hinerman R, Amdur R, et al. Postoperative radiotherapy for squamous cell carcinoma of the head and neck. Clin Med Res 2006;4:200-208.
15. Zelefsky M, Harrison L, Fass D, Armstrong J, Shah J, Strong E. Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins. Int J Radiat Oncol Biol Phys 1993;25:17-21.
16. Batsakis JG. Surgical excision margins: a pathologist's perspective. Adv Anat Pathol 1999;6:140-148.
17. Meier J, Oliver D, Varvares M. Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey. Head Neck 2005;27:952-958.
18. Barnes L, Eveson J, Reichart P, Sidransky D. Pathology and genetics of head and neck tumours. World Health Organization classification of tumours. Lyon: IARC Press; 2005.
19. Janot F, Klijanienko J, Russo A, et al. Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis. Br J Cancer 1996;73:531-538.
20. Anneroth G, Batsakis JG, Luna M. Malignancy grading of squamous cell carcinoma in the floor of the mouth related to clinical evaluation. Scand J Dent Res 1986; 94:347-356.
21. Fukano H, Matsuura H, Hasegawa Y, Nakamura S. Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck 1997;19:205-210.
22. Kurokawa H, Zhang M, Matsumoto S, et al. The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma. J Oral Pathol Med 2005;34:329-333.
23. Rubio Bueno P, Naval Gias L, García Delgado R, Domingo Cebollada J, Díaz González F. Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base. Head Neck 1998;20:232-239.
24. Heppner G. Tumor heterogeneity. Cancer Res 1984;44:2259-2265.
25. Jacob R, Welkoborsky H, Mann W. Heterogeneity of squamous cell carcinomas of the head and neck-analysis of tumor biologic factors and proliferation rates. Laryngoscope 1996;106:1170-1175.
26. Slootweg P, Hordijk G, Schade Y, van Es R, Koole R. Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology. Oral Oncol 2002;38:500-503.
27. Yuen PW, Lam KY, Chan AC, Wei WI, Lam LK. Clinicopathological analysis of local spread of carcinoma of the tongue. Am J Surg 1998;175:242-244.
28. Kudo Y, Kitajima S, Ogawa I, et al. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous p-catenin. Clin Cancer Res 2004;10:5455-5463.